WO2012020991A3 - Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients - Google Patents

Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients Download PDF

Info

Publication number
WO2012020991A3
WO2012020991A3 PCT/KR2011/005853 KR2011005853W WO2012020991A3 WO 2012020991 A3 WO2012020991 A3 WO 2012020991A3 KR 2011005853 W KR2011005853 W KR 2011005853W WO 2012020991 A3 WO2012020991 A3 WO 2012020991A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
tyrosine
preventing
amino acid
active ingredients
Prior art date
Application number
PCT/KR2011/005853
Other languages
French (fr)
Korean (ko)
Other versions
WO2012020991A2 (en
Inventor
임우택
김윤배
이정용
연성호
이진채
구교철
Original Assignee
월드웨이㈜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 월드웨이㈜ filed Critical 월드웨이㈜
Priority to CN2011800493075A priority Critical patent/CN103209697A/en
Publication of WO2012020991A2 publication Critical patent/WO2012020991A2/en
Publication of WO2012020991A3 publication Critical patent/WO2012020991A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

The present invention relates to a composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients and relates to a production method therefor. The composition of the present invention is outstandingly efficacious in Parkinson's disease, cerebral infarction, stroke or dementia.
PCT/KR2011/005853 2010-08-11 2011-08-10 Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients WO2012020991A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011800493075A CN103209697A (en) 2010-08-11 2011-08-10 Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100077583A KR101048657B1 (en) 2010-08-11 2010-08-11 Composition for preventing and inproving of bratin disease containing silk amino acid and tyrosine as active ingredients
KR10-2010-0077583 2010-08-11

Publications (2)

Publication Number Publication Date
WO2012020991A2 WO2012020991A2 (en) 2012-02-16
WO2012020991A3 true WO2012020991A3 (en) 2012-05-24

Family

ID=44923501

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005853 WO2012020991A2 (en) 2010-08-11 2011-08-10 Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients

Country Status (3)

Country Link
KR (1) KR101048657B1 (en)
CN (1) CN103209697A (en)
WO (1) WO2012020991A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6667194B2 (en) * 2014-04-28 2020-03-18 不二製油株式会社 Food additive for producing food for preventing cranial nerve disease or improving brain function
CN104606178A (en) * 2015-02-09 2015-05-13 李健 Application of 2-valeryl-1, 5-cyclohexadiene-1-carboxylic acid in preparing medicine for treating chloasma
KR102107808B1 (en) * 2019-11-12 2020-05-07 주식회사 네이처센스 농업회사법인 Peptides for improving memory cognitive function
KR102107804B1 (en) * 2019-11-12 2020-05-07 주식회사 네이처센스 농업회사법인 Peptides for improving memory cognitive function
KR102107806B1 (en) * 2019-11-12 2020-05-07 주식회사 네이처센스 농업회사법인 Peptide mixture for improving memory cognitive function
EP4173494A1 (en) * 2020-06-30 2023-05-03 Industry-Academic Cooperation Foundation Gyeongsang National University Composition for preventing, ameliorating, or treating diseases caused by nitration of tyrosine in protein, containing tyrosine as active ingredient

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030077902A (en) * 2002-03-27 2003-10-04 대한민국(부경대학교 총장) Composition of anti-diabetes patient food using silkworm product
KR20040073425A (en) * 2004-07-30 2004-08-19 주식회사 바이오그랜드 Compositions for improving brain or cognitive function
WO2006014033A1 (en) * 2004-07-31 2006-02-09 Brainguard Co., Ltd. Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030077902A (en) * 2002-03-27 2003-10-04 대한민국(부경대학교 총장) Composition of anti-diabetes patient food using silkworm product
KR20040073425A (en) * 2004-07-30 2004-08-19 주식회사 바이오그랜드 Compositions for improving brain or cognitive function
WO2006014033A1 (en) * 2004-07-31 2006-02-09 Brainguard Co., Ltd. Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation

Also Published As

Publication number Publication date
WO2012020991A2 (en) 2012-02-16
CN103209697A (en) 2013-07-17
KR101048657B1 (en) 2011-07-12

Similar Documents

Publication Publication Date Title
WO2012020991A3 (en) Composition for preventing and alleviating brain disease comprising silk amino acid and tyrosine as active ingredients
WO2012076466A3 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
MY156777A (en) Substituted 2-acetamido-5-ary1-1,2,4-triazolones and use thereof
TN2012000549A1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
WO2014014835A8 (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
NZ703341A (en) Compositions comprising apomorphine and organic acids and uses thereof
PH12015500106A1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
WO2013184876A8 (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof
MY169980A (en) Bisaryl-linked aryltriazolones and their use
MY156434A (en) Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
SG179120A1 (en) Novel compounds
WO2013134085A8 (en) Inhibitors of beta-secretase
WO2012099449A3 (en) Novel use of flavone-based compound
WO2012040804A3 (en) Synergistic combinations of triazoles, strobilurins and benzimidazoles, uses, formulations, production processes and applications using the same
WO2014035860A8 (en) Inhibitors of beta-secretase
WO2012030106A3 (en) Production method of intermediate compound for synthesizing medicament
WO2011107812A3 (en) Stabilized pharmaceutical composition
WO2013190455A3 (en) Process for the preparation of lurasidone hydrochloride
MX359554B (en) Crystalline microspheres and the process for manufacturing the same.
ZA201300256B (en) Process for preparing crystalline 3,6,9-tris(carboxymethyl)-4-(4-ethoxybenzyl)undecanedioic acid and use for production of primovist
MX2013002261A (en) Substituted n-phenethyltriazoloneacetamides and use thereof.
EP2596787A4 (en) New use of hesperetin
WO2010051138A3 (en) Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof
MD4375C1 (en) Process for the enzymatic synthesis of (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methyl-methanamine and application in the synthesis of ivabradine and salts thereof
UA108277C2 (en) Complex preparation containing lercanidipine hydrochloride and valsartan, and method for production

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11816607

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11816607

Country of ref document: EP

Kind code of ref document: A2